New hope for eye cancer patients with liver spread: targeted chemo shows promise
NCT ID NCT04728633
First seen May 08, 2026 · Last updated May 19, 2026 · Updated 3 times
Summary
This study tests a procedure called chemoembolization for people with uveal melanoma (a type of eye cancer) that has spread to the liver. Doctors inject a chemotherapy drug directly into the liver's blood supply and block the flow to trap the drug near the tumors. The goal is to shrink or control the liver tumors. The study includes 28 adults whose liver tumors are not too large and who have not had this type of liver treatment before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UVEAL MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.